09886 DINGDANG HEALTH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.65X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 5.9% | Net Margin | N/A |
Total Debt/Equity | 9.2% | Return on Equity | N/A |
Price/Book | 0.40X | Return on Assets | N/A |
(HKD 0.530) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -400.41 | -248.89 | -3,176.80 | -1,930.08 | -1,096.90 |
---|---|---|---|---|---|
Net Profit Growth (%) | -60.9 | +92.2 | -64.6 | -76.0 | -254.7 |
Earnings Per Share (HKD) | -0.303 | -0.186 | -3.777 | -4.046 | -4.302 |
Earnings Per Share Growth (%) | -62.9 | +95.1 | +6.7 | +5.9 | -254.7 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 1.338 | 1.674 | 1.827 | N/A | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 4,669 | 4,857 | -3.9 | 4,329 |
Operating Result | -367.856 | -218.709 | +68.2 | -2,832 |
Associates | -1.555 | -2.445 | -36.4 | 0 |
Profit Before Taxation | -370.119 | -221.227 | +67.3 | -2,832 |
Taxation | 9.867 | 9.641 | +2.3 | 10.128 |
Profit /( Loss) After Taxation | -379.986 | -230.868 | +64.6 | -2,842 |
Minority Interests | -3.488 | -5.059 | -31.1 | -8.88 |
Net Profit | -376.498 | -225.809 | +66.7 | -2,833 |
Earnings Per Share () | -0.3028 | -0.1859 | +62.9 | -3.7771 |
Announcement Date | 2025-03-21 | 2024-03-28 | NA | 2023-03-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25